Skip to main content

Table 1 Patient demographics

From: Implementing a comprehensive translational oncology platform: from molecular testing to actionability

 

Breast cancer (n = 19)

Prostate cancer (n = 18)

Pancreatic cancer (n = 1)

Total (n = 38)

Gender

 Male

0

18

1

19

 Female

19

0

0

19

Age in years (median, range)

56

(35–71)

68

(56–80)

82

65

(35–82)

Prior therapies (median, range)

1.5

(0–14)

4

(0–9)

1

3

(0–14)

ECOG PS

 0–1

16

18

1

31

 ≥ 2

3

0

0

3

Research biopsy performed

15

12

1

28

Biopsy cellularity % (median, range)

70

(15–80)

75

(50–90)

80

70

(15–90)

Number of cores (median, range)

5

(3–10)

4.5

(2–7)

20

6

(2–20)